Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

21. Effectiveness of patient-targeted interventions to increase cancer screening participation in rural areas: A systematic review Full Text available with Trip Pro

Effectiveness of patient-targeted interventions to increase cancer screening participation in rural areas: A systematic review Cancer is a major public health problem worldwide. The GLOBOCAN estimated 18.1 million new cases of cancer and 9.6 million deaths from cancer in 2018. In some of the more frequent cancers, mortality can be significantly reduced through cancer screening programs. Nevertheless, socially disadvantaged groups have difficulties in benefitting from these screening programs (...) , especially rural populations.To identify, characterize and summarize patient-targeted interventions aimed at increasing cancer screening participation among rural populations.An exhaustive literature search was performed in the most relevant bibliographic databases for biomedical research. The systematic review was reported according to the PRISMA guidelines.Twenty studies assessing 37 interventions were identified. Most of the studies were conducted in the United States and targeted women. Ninety-seven

2019 EvidenceUpdates

22. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial In the United States, more than 50% of cervical cancers are diagnosed in underscreened women. Cervical cancer screening guidelines now include primary human papillomavirus (HPV) testing as a recommended strategy. Home-based HPV self-sampling is a viable option for increasing screening compliance and effectiveness; however (...) , US data are needed to inform health care system implementation.To evaluate effectiveness of mailed HPV self-sampling kits vs usual care reminders for in-clinic screening to increase detection and treatment of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and uptake of cervical cancer screening.Randomized clinical trial conducted in Kaiser Permanente Washington, a US integrated health care delivery system. Women aged 30 to 64 years with health plan enrollment for 3 years and 5 months

2019 EvidenceUpdates

23. Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review Full Text available with Trip Pro

Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review This systematic review was conducted to inform the Canadian Task Force on Preventive Health Care recommendations on screening for thyroid dysfunction (TD). The review sought to answer key questions on the benefits and harms of screening for TD, patients' values and preferences for screening, and the benefits and harms of treating screen-detected (...) TD.This review followed Canadian Task Force on Preventive Health Care methods, which include the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. The search strategy used for benefits and harms of screening and treatment was an update to the 2014 review by the US Preventive Services Task Force and searched MEDLINE and the Cochrane Library. MEDLINE, Embase, ProQuest Public Health, and SCOPUS were searched for patients' values and preferences for screening. Outcomes

2019 EvidenceUpdates

24. Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis Full Text available with Trip Pro

Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis The DETECT algorithm has been developed to identify SSc patients at risk for pulmonary arterial hypertension (PAH) yielding high sensitivity but low specificity, and positive predictive value. We tested whether cardiopulmonary exercise testing (CPET) could improve the performance of the DETECT screening strategy.Consecutive SSc patients over a 30-month period (...) were screened with the DETECT algorithm and positive subjects were referred for CPET before the execution of right-heart catheterization. The predictive performance of CPET on top of DETECT was evaluated and internally validated via bootstrap replicates.Out of 314 patients, 96 satisfied the DETECT application criteria and 54 were positive. PAH was ascertained in 17 (31.5%) and pre-capillary pulmonary hypertension in 23 (42.6%) patients. Within CPET variables, the slope of the minute ventilation

2019 EvidenceUpdates

25. Screening and Management of the Hyperandrogenic Adolescent

Screening and Management of the Hyperandrogenic Adolescent ACOGCOMMITTEEOPINION Number 789 Committee on Adolescent Health Care This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Adolescent Health Care in collaboration with committee members Jennie Yoost, MD and Ashlyn Savage, MD. Screening and Management of the Hyperandrogenic Adolescent ABSTRACT: Although androgen excess can manifest in many ways, the most common and recognizable (...) of PCOS and those of normal puberty,whichmakesthediagnosisofPCOSintheadolescentdifficult.Treatmentofacneandhirsutismshould not be withheld during the ongoing longitudinal evaluation for possible PCOS. On physical examination, body mass index, blood pressure, and signs of hyperandrogenism, such as acne and hirsutism, should be evaluated. Although guidelines differ on recommended laboratory studies, most include measurement of total testoster- one, free testosterone, or both, and screening

2019 American College of Obstetricians and Gynecologists

26. Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care

Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care | CMAJ Main menu User menu Search Search for this keyword Search for this keyword Guideline Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care Richard Birtwhistle , Kate Morissette , James A. Dickinson , Donna L. Reynolds , Marc T. Avey , Francesca Reyes Domingo , Rachel Rodin (...) of Family Medicine and Community Health Sciences (Dickinson), University of Calgary, Alta.; Dalla Lana School of Public Health and Department of Family and Community Medicine (Reynolds), University of Toronto, Ont.; Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que. KEY POINTS The Canadian Task Force on Preventive Health Care strongly recommends against screening for thyroid dysfunction in asymptomatic nonpregnant adults. Screening for thyroid dysfunction

2019 Canadian Task Force on Preventive Health Care

27. The screening and management of newborns at risk for low blood glucose

The screening and management of newborns at risk for low blood glucose Hypoglycemia in the first hours to days after birth remains one of the most common conditions facing practitioners across Canada who care for newborns. Many cases represent normal physiologic transition to extrauterine life, but another group experiences hypoglycemia of longer duration. This statement addresses key issues for providers of neonatal care, including the definition of hypoglycemia, risk factors, screening (...) protocols, blood glucose levels requiring intervention, and managing care for this condition. Screening, monitoring, and intervention protocols have been revised to better identify, manage, and treat infants who are at risk for persistent, recurrent, or severe hypoglycemia. The role of dextrose gels in raising glucose levels or preventing more persistent hypoglycemia, and precautions to reduce risk for recurrence after leaving hospital, are also addressed. This statement differentiates between

2019 Canadian Paediatric Society

28. Breast screening: Fujifilm Amulet Innovality DBT system evaluation

Breast screening: Fujifilm Amulet Innovality DBT system evaluation Breast screening: Fujifilm Amulet Innovality DBT system evaluation - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Fujifilm (...) Amulet Innovality DBT system evaluation Practical evaluation of the Fujifilm Amulet Innovality digital breast tomosynthesis system used in the NHS breast screening programme. Published 9 December 2019 Last updated 9 December 2019 — From: Documents Ref: PHE publications gateway number GW-935 9 December 2019 Updated the executive summary on page 4. 9 December 2019 First published. Related content Collection Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t

2019 Public Health England

29. Breast screening: Hologic 3Dimensions in 2D mode

Breast screening: Hologic 3Dimensions in 2D mode Breast screening: Hologic 3Dimensions in 2D mode - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Hologic 3Dimensions in 2D mode Practical (...) evaluation of the Hologic 3Dimensions digital mammography system in 2D mode. Published 9 December 2019 From: Documents Ref: PHE publications gateway number GW-934 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents a practical evaluation of the Hologic 3Dimensions digital mammography system

2019 Public Health England

30. Cervical screening: programme overview

Cervical screening: programme overview Cervical screening: programme overview - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Cervical screening: programme overview A description of the NHS cervical screening (...) programme, including evidence on screening and the human papillomavirus (HPV). Published 1 April 2015 Last updated 18 November 2019 — From: Contents is the process of identifying individuals who appear healthy but may be at increased risk of a disease or condition. The process is not perfect and in every screen there are a number of false positive and false negative results. NHS cervical screening programme is available to women and people with a cervix aged 25 to 64 in England. All eligible people who

2019 Public Health England

31. Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism

Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research (...) . www.acfp.ca December 9, 2019 (en français) Helping physicians fatigued by TSH Screening and Subclinical Hypothyroidism Clinical Question: Is there evidence for screening for thyroid function or treating subclinical hypothyroidism? Bottom Line: There is no randomized controlled trial (RCT) of screening for thyroid function [ordering thyroid stimulating hormone (TSH) in non-pregnant healthy people]. Despite approximately 20 RCTs, there are no patient-oriented benefits (like preventing cardiovascular disease

2019 Tools for Practice

32. Abdominal Aortic Aneurysm: Screening

Abdominal Aortic Aneurysm: Screening Final Update Summary: Abdominal Aortic Aneurysm: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 5/9/2019 1:01:08 PM You are here: Final Summary Abdominal Aortic Aneurysm: Screening Release Date: December 2019 Recommendation Summary Population Recommendation Grade Men aged 65 to 75 years who have ever smoked The USPSTF recommends 1-time screening for abdominal aortic aneurysm (AAA (...) ) with ultrasonography in men aged 65 to 75 years who have ever smoked. Men aged 65 to 75 years who have never smoked The USPSTF recommends that clinicians selectively offer screening for AAA with ultrasonography in men aged 65 to 75 years who have never smoked rather than routinely screening all men in this group. Evidence indicates that the net benefit of screening all men in this group is small. In determining whether this service is appropriate in individual cases, patients and clinicians should consider

2019 U.S. Preventive Services Task Force

33. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines

Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines - Crow - 2019 - Transplant International - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Original (...) Article Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines Department of Dermatology, University of California San Francisco, San Francisco, CA, USA Division of Dermatology, Dell Medical School, University of Texas at Austin, Austin, TX, USA Montgomery Dermatology/Lankenau Institute for Medical Research, King of Prussia, PA, USA Advanced Heart Failure Center, Sentara Heart Hospital, Norfolk, VA, USA

2019 International Society for Heart and Lung Transplantation

34. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy Full Text available with Trip Pro

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline | The BMJ Intended for healthcare professionals Username * Password * Edition: Search form Search Search Colorectal cancer... Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline (Published 02 October 2019) Cite (...) this as: BMJ 2019;367:l5515 Visual summary of recommendation No screening FIT Every year FIT Every two years Sigmoidoscopy Single Colonoscopy Single Favours no screening Favours screening We suggest no screening Interventions compared Recommendations Screening options Population We suggest using a tool such as the QCancer® calculator to estimate the risk of colorectal cancer for each person in the next 15 years. This calculates risk, based on: Understanding a person’s risk of cancer can help to determine

2019 BMJ Rapid Recommendations

35. Newborn screening for sickle cell disease

Newborn screening for sickle cell disease 1 Translation of Chapters 1 to 6 of the final report S18-01 Screening auf Sichelzellkrankheit (SCD) bei Neugeborenen (Version 1.0; Status: 25 July 2019 [German original], 28 November 2019 [English translation]). Please note: This document was translated by an external translator and is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Extract IQWiG (...) Reports – Commission No. S18-01 Newborn screening for sickle cell disease (SCD) 1 Extract of final report S18-01 Version 1.0 Newborn screening for sickle cell disease (SCD) 25 July 2019 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Newborn screening for sickle cell disease (SCD) Commissioning agency: Federal Joint Committee Commission awarded on: 28 June 2018 Internal Commission No.: S18-01

2019 Institute for Quality and Efficiency in Healthcare (IQWiG)

36. Effect of Depression Screening After Acute Coronary Syndromes on Quality of Life: The CODIACS-QoL Randomized Clinical Trial (Abstract)

Effect of Depression Screening After Acute Coronary Syndromes on Quality of Life: The CODIACS-QoL Randomized Clinical Trial Patients with acute coronary syndrome (ACS) and elevated depressive symptoms are at increased risk for recurrent cardiovascular events and mortality, worse quality of life, and higher health care costs. These observational findings prompted multiple scientific panels to advise universal depression screening in survivors of ACS prior to evidence from randomized screening (...) trials.To determine whether systematically screening for depression in survivors of ACS improves quality of life and depression compared with usual care.A 3-group multisite randomized trial enrolled 1500 patients with ACS from 4 health care systems between November 1, 2013, and March 31, 2017, with follow-up ending July 31, 2018. Patients were eligible if they had been hospitalized for ACS in the previous 2 to 12 months and had no prior history of depression. All analyses were performed on an intention

2019 EvidenceUpdates

37. Performance and Usability of Machine Learning for Screening in Systematic Reviews: A Comparative Evaluation of Three Tool

Performance and Usability of Machine Learning for Screening in Systematic Reviews: A Comparative Evaluation of Three Tool Methods Research Report Performance and Usability of Machine Learning for Screening in Systematic Reviews: A Comparative Evaluation of Three Tools Methods Research Report Performance and Usability of Machine Learning for Screening in Systematic Reviews: A Comparative Evaluation of Three Tools Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health (...) and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00001-I Prepared by: University of Alberta Evidence-based Practice Center Edmonton, Alberta, Canada Investigators: Allison Gates, Ph.D. Samantha Guitard, M.Sc. Jennifer Pillay, M.Sc. Sarah A. Elliott, Ph.D. Michele P. Dyson, Ph.D. Amanda S. Newton, Ph.D., R.N. Lisa Hartling, Ph.D. AHRQ Publication No. 19(20)-EHC027-EF November 2019 ii Key Messages Purpose of project For title and abstract screening, we explored

2019 Effective Health Care Program (AHRQ)

38. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis Full Text available with Trip Pro

Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis Evaluate effectiveness, harms and burdens of faecal blood testing, sigmoidoscopy and colonoscopy screening for colorectal cancer over 15 years.We performed an update of a Cochrane systematic review, and performed network meta-analysis comparing randomised trials evaluating colorectal cancer screening with guaiac faecal occult blood test (gFOBT) (annual, biennial), faecal (...) immunochemical test (FIT) (annual, biennial), sigmoidoscopy (once-only) or colonoscopy (once-only) in a healthy population, aged 50-79 years. We conducted subgroup analysis on sex. Follow-up >5 years was required for analysis of colorectal cancer incidence and mortality.12 randomised trials proved eligible. Compared with no-screening, we found high certainty evidence for sigmoidoscopy screening slightly reducing colorectal cancer incidence (relative risk (RR) 0.76; 95% confidence interval (CI 0.70 to 0.83

2019 EvidenceUpdates

39. Use of electronic screen media prior to dental appointment can help to reduce anxiety in patients with Autism Spectrum Disorder

Use of electronic screen media prior to dental appointment can help to reduce anxiety in patients with Autism Spectrum Disorder UTCAT3390, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Use of electronic screen media prior to dental appointment can help to reduce anxiety in patients with Autism Spectrum Disorder Clinical Question Can use of electronic screen media prior to dental appointment help reduce anxiety (...) in patients with Autism Spectrum Disorder? Clinical Bottom Line For children with Autism Spectrum Disorder (ASD), certain types of electronic screen media may be helpful to reduce anxiety during dental appointments. This randomized controlled study based on 80 subjects found that electronic screen media could be used to reduce anxiety in children with ASD. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Isong

2019 UTHSCSA Dental School CAT Library

40. Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study

Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Methods Research Report Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Methods Research Report Assessing the Accuracy of Machine-Assisted Abstract Screening With DistillerAI: A User Study Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290 (...) 3 Department of Family Medicine, Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands AHRQ Publication No. 19(20)-EHC026 -EF November 2019 ii Key Messages Purpose of the report This report summarizes a methods study that evaluated the accuracy of a machine-assisted abstract screening approach that temporarily replaced a human screener with a semi-automated screening tool. Key messages • Results of our study rendered a mean sensitivity of 78 percent

2019 Effective Health Care Program (AHRQ)